(3-Chloro-5-cyanophenyl)boronic acid | CAS:915763-60-9

We serve (3-Chloro-5-cyanophenyl)boronic acid CAS:915763-60-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3-Chloro-5-cyanophenyl)boronic acid

3-氰基-5-氯苯硼酸
Product Name: (3-Chloro-5-cyanophenyl)boronic acid
Other Name:
(3-Chloro-5-cyanophenyl)boronic acid
3-chloro-5-cyanophenylboronic acid
CAS No: 915763-60-9
MF: C7H5BClNO2
MW: 181.38400
Density: N/A
Boiling point: N/A
Melting point: N/A
Flash point: N/A
Refractive index: N/A
UN Number: Non-dangerous goods
Transport hazard class: Non-dangerous goods
Packing group: Non-dangerous goods
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like (3-Chloro-5-cyanophenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-chloro-5-cyanophenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-chloro-5-cyanophenylboronic acid Use and application,3-chloro-5-cyanophenylboronic acid technical grade,usp/ep/jp grade.


Related News: This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.5-Amino-1,3,4-thiadiazole-2-thiol manufacturer Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.ethyl isothiocyanate supplier Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.Magnesium (R)-3-hydroxybutanoate vendor Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.